Daclizumab cuts MS relapse rate by 45%, according to DECIDE study #AAN15: http://bit.ly/1DOxbKu
12:05 PM - 22 Apr 2015
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.